[go: up one dir, main page]

NO20061404L - Renseprosess - Google Patents

Renseprosess

Info

Publication number
NO20061404L
NO20061404L NO20061404A NO20061404A NO20061404L NO 20061404 L NO20061404 L NO 20061404L NO 20061404 A NO20061404 A NO 20061404A NO 20061404 A NO20061404 A NO 20061404A NO 20061404 L NO20061404 L NO 20061404L
Authority
NO
Norway
Prior art keywords
acid addition
free base
cleaning process
addition form
terbinafine
Prior art date
Application number
NO20061404A
Other languages
English (en)
Norwegian (no)
Inventor
Gerhard Penn
Ulrich Beutler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061404(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20061404L publication Critical patent/NO20061404L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/84Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20061404A 2003-08-29 2006-03-28 Renseprosess NO20061404L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process
PCT/EP2004/009587 WO2005021483A2 (en) 2003-08-29 2004-08-27 Process for the purification of terbinafine

Publications (1)

Publication Number Publication Date
NO20061404L true NO20061404L (no) 2006-08-25

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061404A NO20061404L (no) 2003-08-29 2006-03-28 Renseprosess

Country Status (25)

Country Link
US (2) US20060076227A1 (ru)
EP (1) EP1694631A2 (ru)
JP (1) JP5208416B2 (ru)
KR (2) KR20120054109A (ru)
CN (1) CN100491334C (ru)
AR (1) AR045506A1 (ru)
AU (1) AU2004268051B2 (ru)
BR (1) BRPI0413896A (ru)
CA (1) CA2536498C (ru)
EC (1) ECSP066382A (ru)
GB (1) GB0320312D0 (ru)
IL (1) IL173709A (ru)
IS (1) IS8369A (ru)
MA (1) MA28030A1 (ru)
MX (1) MXPA06002348A (ru)
MY (1) MY149357A (ru)
NO (1) NO20061404L (ru)
NZ (1) NZ545445A (ru)
PE (1) PE20050873A1 (ru)
RU (1) RU2367649C2 (ru)
SG (1) SG145782A1 (ru)
TN (1) TNSN06066A1 (ru)
TW (1) TWI350829B (ru)
WO (1) WO2005021483A2 (ru)
ZA (1) ZA200601264B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (en) * 2006-08-31 2008-03-19 Novartis AG Pharmaceutical compositions for the treatment of fungal infections
WO2010027468A1 (en) 2008-09-05 2010-03-11 Travanti Pharma Inc. Iontophoretic drug delivery packaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE19975055I1 (de) 1979-08-22 2000-01-27 Novartis Ag Propenylamine Verfahren zu ihrer Herstellung sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwending als Arzneimittel
CS232849B1 (cs) * 1983-05-04 1985-02-14 Ladislav Kalvoda Způsob přípravy honjugavaných eninů
RU2005717C1 (ru) * 1989-02-17 1994-01-15 Такеда кемикал-индастриз Лтд Способ получения производных аралкиламинов или их кислотно-аддитивных солей
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) * 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6770786B1 (en) 1999-10-22 2004-08-03 Richter Gedeon Vegyeszeti Gyar Rt. Process for preparing a substituted allylamine derivative and the salts thereof
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) * 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) * 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
AU2004268051B2 (en) 2009-03-05
KR20060119892A (ko) 2006-11-24
MA28030A1 (fr) 2006-07-03
MY149357A (en) 2013-08-30
JP5208416B2 (ja) 2013-06-12
ECSP066382A (es) 2006-09-18
AU2004268051A1 (en) 2005-03-10
IL173709A0 (en) 2006-07-05
WO2005021483A2 (en) 2005-03-10
BRPI0413896A (pt) 2006-10-24
IL173709A (en) 2012-02-29
JP2007504110A (ja) 2007-03-01
US20090216047A1 (en) 2009-08-27
ZA200601264B (en) 2007-06-27
CA2536498C (en) 2012-10-09
CN1845895A (zh) 2006-10-11
TW200523231A (en) 2005-07-16
NZ545445A (en) 2010-03-26
GB0320312D0 (en) 2003-10-01
KR20120054109A (ko) 2012-05-29
WO2005021483A3 (en) 2005-05-12
CN100491334C (zh) 2009-05-27
CA2536498A1 (en) 2005-03-10
AR045506A1 (es) 2005-11-02
US7985323B2 (en) 2011-07-26
RU2006109640A (ru) 2007-10-10
TNSN06066A1 (en) 2007-10-03
EP1694631A2 (en) 2006-08-30
SG145782A1 (en) 2008-09-29
MXPA06002348A (es) 2006-05-22
KR101233024B1 (ko) 2013-02-13
IS8369A (is) 2006-03-23
TWI350829B (en) 2011-10-21
PE20050873A1 (es) 2005-11-21
US20060076227A1 (en) 2006-04-13
RU2367649C2 (ru) 2009-09-20

Similar Documents

Publication Publication Date Title
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
JP2011513402A5 (ru)
NO20071866L (no) Prosesser for beskyttelse av optisk aktive aminderivater
DE502004004307D1 (de) Verfahren zur herstellung von gereinigten 1,3-substituierten imidazoliumsalzen
BRPI0519106A2 (pt) compostos, uso destes, processo para sua fabricaÇço, composiÇÕes farmacÊuticas, mÉtodo para o tratamento e/ou profilaxia de doenÇas que sço associadas com a dpp-iv
ATE424384T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendungen
EA200800401A1 (ru) Промежуточное соединение для синтеза фармацевтического средства и способ его получения
JO2478B1 (en) (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
NO20061404L (no) Renseprosess
RU2007116037A (ru) Новая кристаллическая форма (3-циано-1н-индол-7-ил)-[4-(4-фторфенэтил)пиперазин-1-ил]метанона, гидрохлорида
JP2008514558A5 (ru)
JP2011511053A5 (ru)
WO2015189862A4 (en) Chiral amines, a process for preparation and use thereof
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
JP2011506528A5 (ru)
DE602004025132D1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
CN107365301B (zh) 一种克唑替尼的合成方法及其中间体制备方法
JP2008540413A5 (ru)
JP2003523364A5 (ru)
CY1107097T1 (el) 5ht4-ανταγωνιστικα βενζαμιδια 4-( αμινομεθυλ) - πιπεριδινης
CN105727829B (zh) 一种聚硅氧烷表面活性离子液体及其制备方法
WO2002083554A3 (de) Verfahren zur herstellung von hochreiner salpetersäure
EP1728787A4 (en) Method for purifying 2-chloro-5-chloromethyl-1,3-thiazole
CN103922907B (zh) 一种金刚烷甲醛的制备方法

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application